Glass or plastic? In the prefillable syringe (PFS) market, the answer increasingly will be plastic, according to medtech consultancy Greystone Associates. While PFS suppliers continue to compete for customers in a sector reporting double-digit annual unit growth, leading companies are quietly manoeuvring to gain advantage in the next major PFS battleground—syringes constructed of plastic rather than glass. Greystone Associates has published a comprehensive report on the PFS market’s key technological, business and regulatory factors.
Medical plastics manufacturers have turned to new materials such as cyclic olefin copolymers (COCs) to replace the polypropylene (PP), typically used for non-prefillable disposable syringes, for prefilled applications, notes the report. COCs and related materials feature heat resistance and minimal extractables and leachables. They are also less permeable to water than PP-based materials. Because of their inert surface and break resistance, these syringes are considered suitable for use in the demanding area of cytostatics and biopharmaceutics.
More information is available at www.greystoneassociates.org.Norbert Sparrow